Analysis of HLA-G Polymorphisms in Couples with Implantation Failure

American Journal of Reproductive Immunology

Volumn 68, Issue 6, 2012, Pages 507-514

  Nardi, Fabiola da Silva ^a   Slowik, Renata ^a   Wowk, Pryscilla Fanini ^a   da Silva, José Samuel ^a   Gelmini, Geórgia Fernanda ^a   Michelon, Tatiana Ferreira ^b   Neumann, Jorge ^b   Bicalho, Maria da Graça ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b Reproductive Immunology Centre   (Brazil)

Author keywords

Assisted reproduction treatment; HLA G; soluble HLA G; Implantation failure

Indexed keywords

HLA G ANTIGEN;

ADULT; ALLELE; ARTICLE; BLOOD LEVEL; CONTROL GROUP; CONTROLLED STUDY; EMBRYO; EMBRYO TRANSFER; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; FEMALE; FEMALE INFERTILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMPLANT; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; MOTHER FETUS RELATIONSHIP; NIDATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT FAILURE;

ABORTION, HABITUAL; ABORTION, SPONTANEOUS; ADULT; ALLELES; CASE-CONTROL STUDIES; EMBRYO IMPLANTATION; FEMALE; GENETIC VARIATION; GENOTYPE; HLA-G ANTIGENS; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY;

EID: 84869088042     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12001     Document Type: Article

References (35)

1. Kling C, Schmutzler A, Wilke G, Hedderich J, Kabelitz D: Two-year outcome after recurrent implantation failure: prognostic factors and additional interventions. Arch Gynecol Obstet 2008; 278:135-142.
2. Allen VM, Wilson RD, Cheung A: Pregnancy outcomes after assisted reproductive technology. J Obstet Gynaecol Can 2006; 28:220-250.
3. Myers ER, McCrory DC, Mills AA, Price TM, Swamy GK, Tantibhedhyangkul J, Wu JM, Matchar DB: Effectiveness of assisted reproductive technology (ART). Evid Rep Technol Assess (Full Rep) 2008; 167:1-195.
4. Pauli SA, Berga SL, Shang W, Session DR: Current status of the approach to assisted reproduction. Pediatr Clin North Am 2009; 56:467-488, Table of Contents.
5. Urman B, Yakin K, Balaban B: Recurrent implantation failure in assisted reproduction: how to counsel and manage. A. General considerations and treatment options that may benefit the couple. Reprod Biomed Online 2005; 11:371-381.
6. Senturk LM, Erel CT: Thin endometrium in assisted reproductive technology. Curr Opin Obstet Gynecol 2008; 20:221-228.
7. Rizzo R, Vercammen M, van de Velde H, Horn PA, Rebmann V: The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells. Cell Mol Life Sci 2011; 68:341-352.
8. Margalioth EJ, Ben-Chetrit A, Gal M, Eldar-Geva T: Investigation and treatment of repeated implantation failure following IVF-ET. Hum Reprod 2006; 21:3036-3043.
9. Lessey BA: Assessment of endometrial receptivity. Fertil Steril 2011; 96:522-529.
10. Carver J, Martin K, Spyropoulou I, Barlow D, Sargent I, Mardon H: An in-vitro model for stromal invasion during implantation of the human blastocyst. Hum Reprod 2003; 18:283-290.
11. Roussev RG, Coulam CB: HLA-G and its role in implantation (review). J Assist Reprod Genet 2007; 24:288-295.
12. Puppo F, Ghio M, Contini P, Brenci S, Bignardi D, Filaci G, Scudeletti M, Indiveri F: Immunoregulatory role of soluble HLA molecules: a new skin for an old subject? Arch Immunol Ther Exp (Warsz) 1998; 46:157-160.
13. Alegre E, Diaz-Lagares A, Lemaoult J, Lopez-Moratalla N, Carosella ED, Gonzalez A: Maternal antigen presenting cells are a source of plasmatic HLA-G during pregnancy: longitudinal study during pregnancy. Hum Immunol 2007; 68:661-667.
14. Moreau P, Flajollet S, Carosella ED: Non-classical transcriptional regulation of HLA-G: an update. J Cell Mol Med 2009; 13:2973-2989.
15. Vercammen M, Verloes A, Haentjens P, Van de Velde H: Can soluble human leucocyte antigen-G predict successful pregnancy in assisted reproductive technology? Curr Opin Obstet Gynecol 2009; 21:285-290.
16. Hunt JS: Stranger in a strange land. Immunol Rev 2006; 213:36-47.
17. Rebmann V, LeMaoult J, Rouas-Freiss N, Carosella ED, Grosse-Wilde H: Quantification and identification of soluble HLA-G isoforms. Tissue Antigens 2007; 69(Suppl 1):143-149.
18. Athanassakis I, Paflis M, Ranella A, Vassiliadis S: Detection of soluble HLA-G levels in maternal serum can be predictive for a successful pregnancy. Transplant Proc 1999; 31:1834-1837.
19. Ghazeeri GS, Kutteh WH: Immunological testing and treatment in reproduction: frequency assessment of practice patterns at assisted reproduction clinics in the USA and Australia. Hum Reprod 2001; 16:2130-2135.
20. Schieve LA, Tatham L, Peterson HB, Toner J, Jeng G: Spontaneous abortion among pregnancies conceived using assisted reproductive technology in the United States. Obstet Gynecol 2003; 101:959-967.
21. Lahiri DK, Nurnberger JI Jr: A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991; 19:5444.
22. Excoffier L, Lischer HE: Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour 2010; 10:564-567.
23. Guo SW, Thompson EA: A Monte Carlo method for combined segregation and linkage analysis. Am J Hum Genet 1992; 51:1111-1126.
24. Osmanagaoglu K, Tournaye H, Camus M, Vandervorst M, Van Steirteghem A, Devroey P: Cumulative delivery rates after intracytoplasmic sperm injection: 5 year follow-up of 498 patients. Hum Reprod 1999; 14:2651-2655.
25. Sharma V, Allgar V, Rajkhowa M: Factors influencing the cumulative conception rate and discontinuation of in vitro fertilization treatment for infertility. Fertil Steril 2002; 78:40-46.
26. Witsenburg C, Dieben S, Van der Westerlaken L, Verburg H, Naaktgeboren N: Cumulative live birth rates in cohorts of patients treated with in vitro fertilization or intracytoplasmic sperm injection. Fertil Steril 2005; 84:99-107.
27. Schroder AK, Katalinic A, Diedrich K, Ludwig M: Cumulative pregnancy rates and drop-out rates in a German IVF programme: 4102 cycles in 2130 patients. Reprod Biomed Online 2004; 8:600-606.
28. Christiansen OB, Ring M, Rosgaard A, Grunnet N, Gluud C: Association between HLA-DR1 and -DR3 antigens and unexplained repeated miscarriage. Hum Reprod Update 1999; 5:249-255.
29. Ober C, Hyslop T, Elias S, Weitkamp LR, Hauck WW: Human leukocyte antigen matching and fetal loss: results of a 10 year prospective study. Hum Reprod 1998; 13:33-38.
30. Abbas A, Tripathi P, Naik S, Agrawal S: Analysis of human leukocyte antigen (HLA)-G polymorphism in normal women and in women with recurrent spontaneous abortions. Eur J Immunogenet 2004; 31:275-278.
31. Vargas RG, Sarturi PR, Mattar SB, Bompeixe EP, Silva Jdos S, Pirri A, Bicalho Mda G: Association of HLA-G alleles and 3′ UTR 14 bp haplotypes with recurrent miscarriage in Brazilian couples. Hum Immunol 2011; 72:479-485.
32. Aldrich CL, Stephenson MD, Karrison T, Odem RR, Branch DW, Scott JR, Schreiber JR, Ober C: HLA-G genotypes and pregnancy outcome in couples with unexplained recurrent miscarriage. Mol Hum Reprod 2001; 7:1167-1172.
33. Mueller-Eckhardt G, Mallmann P, Neppert J, Lattermann A, Melk A, Heine O, Pfeiffer R, Zingsem J, Domke N, Mohr-Pennert A: Immunogenetic and serological investigations in nonpregnant and in pregnant women with a history of recurrent spontaneous abortions. German RSA/IVIG Study Group. J Reprod Immunol 1994; 27:95-109.
34. Lanier LL: NK cell recognition. Annu Rev Immunol 2005; 23:225-274.
35. Rebmann V, van der Ven K, Passler M, Pfeiffer K, Krebs D, Grosse-Wilde H: Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue Antigens 2001; 57:15-21.